These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24049440)

  • 21. Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria.
    Meloni ST; Agaba P; Chang CA; Yiltok E; Oguche S; Ejeliogu E; Agbaji O; Okonkwo P; Kanki PJ
    PLoS One; 2020; 15(7):e0236801. PubMed ID: 32735566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana.
    Bisson GP; Rowh A; Weinstein R; Gaolathe T; Frank I; Gross R
    J Acquir Immune Defic Syndr; 2008 Sep; 49(1):107-10. PubMed ID: 18667926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low Virologic Failure and Drug Resistance among HIV-Infected Patients Receiving Hospital-Based ART While Care and Outreach through Community in Guangxi, China.
    Liang S; Shen Z; Yan J; Liang F; Tang Z; Liu W; Kan W; Liao L; Leng X; Ruan Y; Xing H; Shao Y
    Front Public Health; 2015; 3():244. PubMed ID: 26579506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond clinical trials: Cross-sectional associations of combination antiretroviral therapy with reports of multiple symptoms and non-adherence among adolescents in South Africa.
    Natukunda HPM; Cluver LD; Toska E; Musiime V; Yakubovich AR
    S Afr Med J; 2017 Oct; 107(11):965-975. PubMed ID: 29262938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions to improve adherence to antiretroviral therapy in children with HIV infection.
    Bain-Brickley D; Butler LM; Kennedy GE; Rutherford GW
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD009513. PubMed ID: 22161452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern.
    Muri L; Gamell A; Ntamatungiro AJ; Glass TR; Luwanda LB; Battegay M; Furrer H; Hatz C; Tanner M; Felger I; Klimkait T; Letang E;
    AIDS; 2017 Jan; 31(1):61-70. PubMed ID: 27677163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure.
    Boerma RS; Bunupuradah T; Dow D; Fokam J; Kariminia A; Lehman D; Kityo C; Musiime V; Palumbo P; Schoffelen A; Sophan S; Zanoni B; Rinke de Wit TF; Calis JCJ; Sigaloff KCE;
    J Int AIDS Soc; 2017 Sep; 20(1):21930. PubMed ID: 28953325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.
    Bussmann H; Wester CW; Thomas A; Novitsky V; Okezie R; Muzenda T; Gaolathe T; Ndwapi N; Mawoko N; Widenfelt E; Moyo S; Musonda R; Mine M; Makhema J; Moffat H; Essex M; Degruttola V; Marlink RG
    J Acquir Immune Defic Syndr; 2009 May; 51(1):37-46. PubMed ID: 19282782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-line antiretroviral therapy: long-term outcomes in South Africa.
    Murphy RA; Sunpath H; Castilla C; Ebrahim S; Court R; Nguyen H; Kuritzkes D; Marconi VC; Nachega JB
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):158-163. PubMed ID: 22692090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychiatric Disorders, Antiretroviral Medication Adherence and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults.
    Bucek A; Leu CS; Benson S; Warne P; Abrams EJ; Elkington KS; Dolezal C; Wiznia A; Mellins CA
    Pediatr Infect Dis J; 2018 Jul; 37(7):673-677. PubMed ID: 29227462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Current CD4+ T Cell Count Predicts Suboptimal Adherence to Antiretroviral Therapy.
    Pasternak AO; de Bruin M; Bakker M; Berkhout B; Prins JM
    PLoS One; 2015; 10(10):e0140791. PubMed ID: 26468956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.
    Nachega JB; Hislop M; Dowdy DW; Chaisson RE; Regensberg L; Maartens G
    Ann Intern Med; 2007 Apr; 146(8):564-73. PubMed ID: 17438315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to antiretroviral treatment among children and adolescents in Tanzania: Comparison between pill count and viral load outcomes in a rural context of Mwanza region.
    Martelli G; Antonucci R; Mukurasi A; Zepherine H; Nöstlinger C
    PLoS One; 2019; 14(3):e0214014. PubMed ID: 30897131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of adolescents living with HIV receiving care and treatment services in antiretroviral therapy clinics in Cambodia: descriptive findings from a cross-sectional study.
    Yi S; Tuot S; Pal K; Khol V; Sok S; Chhoun P; Ferguson L; Mburu G
    BMC Health Serv Res; 2018 Oct; 18(1):781. PubMed ID: 30326882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of antiretroviral therapy adherence among older adolescents living with HIV in Kenya during the transition to adult care; An observational study.
    Gitahi-Kamau N; Wahome S; Bukusi EA; Ngure K
    J AIDS HIV Res; 2020 Jul; 12(2):24-33. PubMed ID: 34540322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy.
    Singini I; Campbell TB; Smeaton LM; Kumarasamy N; La Rosa A; Taejareonkul S; Safren SA; Flanigan TP; Hakim JG; Hughes MD;
    HIV Clin Trials; 2016; 17(5):173-180. PubMed ID: 27472067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Associated with Viral Suppression Among Adolescents on Antiretroviral Therapy in Homa Bay County, Kenya: A Retrospective Cross-Sectional Study.
    Mwangi A; van Wyk B
    HIV AIDS (Auckl); 2021; 13():1111-1118. PubMed ID: 34992469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditional economic incentives and motivational interviewing to improve adolescents' retention in HIV care and adherence to antiretroviral therapy in Southeast Nigeria: study protocol for a cluster randomised trial.
    Ekwunife OI; Anetoh MU; Kalu SO; Ele PU; Eleje GU
    Trials; 2018 Dec; 19(1):710. PubMed ID: 30594223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.